International Neuroblastoma Risk Group [20] uses histologic category, age, grade, MYCN status, DNA ploidy, etc., as a risk group for NBL patients, which helps to develop individualized treatment options according to different risk characteristics. The gene discussed is MYCN; the disease is neuroblastoma.